Losartan potassium and Organising pneumonia - a phase IV clinical study of FDA data

Summary:

Organising pneumonia is reported as a side effect among people who take Losartan potassium (losartan potassium), especially for people who are male, 60+ old, have been taking the drug for 5 - 10 years also take Euthyrox, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Organising pneumonia when taking Losartan potassium. It is created by eHealthMe based on reports of 50,026 people who have side effects when taking Losartan potassium from the FDA, and is updated regularly.

What is Losartan potassium?

Losartan potassium has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 51,515 Losartan potassium users. Check the latest studies of Losartan potassium.

What is Organising pneumonia?

Organising pneumonia (pathologically by the presence in the distal air spaces of buds of granulation tissue) is found to be associated with 438 drugs and 490 conditions by eHealthMe. Check the latest studies of Organising pneumonia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

50,026 people reported to have side effects when taking Losartan potassium.
Among them, 21 people (0.04%) have Organising pneumonia.

Could Losartan potassium cause Organising pneumonia?

Among these 21 people:

How long have people been on Losartan potassium when they have Organising pneumonia? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 100 %
  • 10+ years: 0.0 %

What is the gender of people who have Organising pneumonia when taking Losartan potassium? *

  • female: 45 %
  • male: 55 %

What is the age of people who have Organising pneumonia when taking Losartan potassium? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 7.14 %
  • 60+: 92.86 %

What are other drugs people take besides Losartan potassium? *

  1. Xanax: 6 people, 28.57%
  2. Actonel: 6 people, 28.57%
  3. Euthyrox: 6 people, 28.57%
  4. Melatonin: 5 people, 23.81%
  5. Vitamin D2: 5 people, 23.81%
  6. Nasonex: 5 people, 23.81%
  7. Prednisone: 5 people, 23.81%
  8. Bactrim Ds: 5 people, 23.81%
  9. Calciparine: 4 people, 19.05%
  10. Omeprazole: 4 people, 19.05%

What are other side effects people have besides Organising pneumonia? *

  1. Pneumonia: 9 people, 42.86%
  2. Idiopathic Pulmonary Fibrosis (chronic lung disease): 6 people, 28.57%
  3. Interstitial Lung Disease: 6 people, 28.57%
  4. Nasopharyngitis (inflammation of the nasopharynx): 5 people, 23.81%
  5. Otitis (ear infection): 5 people, 23.81%
  6. Joint Pain: 4 people, 19.05%
  7. Cardiac Failure: 4 people, 19.05%
  8. Eosinophilia (eosinophil count in the peripheral blood exceeds): 4 people, 19.05%
  9. Pneumomediastinum (air is present in the mediastinum): 4 people, 19.05%
  10. Acute Respiratory Failure: 4 people, 19.05%

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 5 people, 23.81%
  2. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 4 people, 19.05%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 14.29%
  4. Psoriasis (immune-mediated disease that affects the skin): 2 people, 9.52%
  5. Portopulmonary Hypertension (coexistence of portal and pulmonary hypertension): 2 people, 9.52%
  6. Infection: 1 person, 4.76%
  7. Constipation: 1 person, 4.76%
  8. Cough: 1 person, 4.76%
  9. Faeces Hard: 1 person, 4.76%
  10. Fungal Infection: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Losartan potassium and have Organising pneumonia?

- Check whether Organising pneumonia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Losartan potassium:

Organising pneumonia treatments and more:

How severe was Organising pneumonia and when was it recovered:

Expand to all the drugs that have ingredients of losartan potassium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Losartan potassium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Organising pneumonia:

Browse all the conditions that are associated with Organising pneumonia:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on losartan potassium (the active ingredients of Losartan potassium) and Losartan potassium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: